chr6-116877840-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_173560.4(RFX6):c.268G>A(p.Ala90Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A90A) has been classified as Likely benign.
Frequency
Consequence
NM_173560.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RFX6 | NM_173560.4 | c.268G>A | p.Ala90Thr | missense_variant | 2/19 | ENST00000332958.3 | |
RFX6 | XM_011535589.2 | c.268G>A | p.Ala90Thr | missense_variant | 2/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RFX6 | ENST00000332958.3 | c.268G>A | p.Ala90Thr | missense_variant | 2/19 | 1 | NM_173560.4 | P1 | |
RFX6 | ENST00000487683.5 | n.332G>A | non_coding_transcript_exon_variant | 2/14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251468Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135918
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727194
GnomAD4 genome AF: 0.000447 AC: 68AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.000537 AC XY: 40AN XY: 74434
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Monogenic diabetes Benign:1
Likely benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Dec 21, 2018 | ACMG criteria: BP4 ( REVEL 0.028 + 9 predictors), BP1 (heterozygous variants that cause MODY with reduced penetrance are LOF per PMID: 29026101), BP1 (htz variants that cause MODY with reduced penetrance are LOF per PMID: 29026101) = likely benign - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at